Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics
Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expr...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Farahbakhsh-Farsi, Payam [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Journal of diabetes & metabolic disorders - London : BioMed Centra, 2012, 13(2014), 1 vom: 06. Jan. |
|---|---|
| Übergeordnetes Werk: |
volume:13 ; year:2014 ; number:1 ; day:06 ; month:01 |
| Links: |
|---|
| DOI / URN: |
10.1186/2251-6581-13-1 |
|---|
| Katalog-ID: |
SPR033832560 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR033832560 | ||
| 003 | DE-627 | ||
| 005 | 20230519173122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/2251-6581-13-1 |2 doi | |
| 035 | |a (DE-627)SPR033832560 | ||
| 035 | |a (SPR)2251-6581-13-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Farahbakhsh-Farsi, Payam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 | ||
| 520 | |a Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. | ||
| 650 | 4 | |a Omega-3 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acylation stimulating protein receptor (C5L2) |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Type 2 diabetes mellitus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Gene expression |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Djalali, Mahmoud |4 aut | |
| 700 | 1 | |a Koohdani, Fariba |4 aut | |
| 700 | 1 | |a Saboor-Yaraghi, Ali Akbar |4 aut | |
| 700 | 1 | |a Eshraghian, Mohammad Reza |4 aut | |
| 700 | 1 | |a Javanbakht, Mohammad Hassan |4 aut | |
| 700 | 1 | |a Chamari, Maryam |4 aut | |
| 700 | 1 | |a Djazayery, Abolghassem |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of diabetes & metabolic disorders |d London : BioMed Centra, 2012 |g 13(2014), 1 vom: 06. Jan. |w (DE-627)723900051 |w (DE-600)2680289-2 |x 2251-6581 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2014 |g number:1 |g day:06 |g month:01 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/2251-6581-13-1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2014 |e 1 |b 06 |c 01 | ||
| author_variant |
p f f pff m d md f k fk a a s y aas aasy m r e mr mre m h j mh mhj m c mc a d ad |
|---|---|
| matchkey_str |
article:22516581:2014----::fetfmg3upeettovrupaeoncltosiuaigrtircpog |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1186/2251-6581-13-1 doi (DE-627)SPR033832560 (SPR)2251-6581-13-1-e DE-627 ger DE-627 rakwb eng Farahbakhsh-Farsi, Payam verfasserin aut Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 Djalali, Mahmoud aut Koohdani, Fariba aut Saboor-Yaraghi, Ali Akbar aut Eshraghian, Mohammad Reza aut Javanbakht, Mohammad Hassan aut Chamari, Maryam aut Djazayery, Abolghassem aut Enthalten in Journal of diabetes & metabolic disorders London : BioMed Centra, 2012 13(2014), 1 vom: 06. Jan. (DE-627)723900051 (DE-600)2680289-2 2251-6581 nnns volume:13 year:2014 number:1 day:06 month:01 https://dx.doi.org/10.1186/2251-6581-13-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2014 1 06 01 |
| spelling |
10.1186/2251-6581-13-1 doi (DE-627)SPR033832560 (SPR)2251-6581-13-1-e DE-627 ger DE-627 rakwb eng Farahbakhsh-Farsi, Payam verfasserin aut Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 Djalali, Mahmoud aut Koohdani, Fariba aut Saboor-Yaraghi, Ali Akbar aut Eshraghian, Mohammad Reza aut Javanbakht, Mohammad Hassan aut Chamari, Maryam aut Djazayery, Abolghassem aut Enthalten in Journal of diabetes & metabolic disorders London : BioMed Centra, 2012 13(2014), 1 vom: 06. Jan. (DE-627)723900051 (DE-600)2680289-2 2251-6581 nnns volume:13 year:2014 number:1 day:06 month:01 https://dx.doi.org/10.1186/2251-6581-13-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2014 1 06 01 |
| allfields_unstemmed |
10.1186/2251-6581-13-1 doi (DE-627)SPR033832560 (SPR)2251-6581-13-1-e DE-627 ger DE-627 rakwb eng Farahbakhsh-Farsi, Payam verfasserin aut Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 Djalali, Mahmoud aut Koohdani, Fariba aut Saboor-Yaraghi, Ali Akbar aut Eshraghian, Mohammad Reza aut Javanbakht, Mohammad Hassan aut Chamari, Maryam aut Djazayery, Abolghassem aut Enthalten in Journal of diabetes & metabolic disorders London : BioMed Centra, 2012 13(2014), 1 vom: 06. Jan. (DE-627)723900051 (DE-600)2680289-2 2251-6581 nnns volume:13 year:2014 number:1 day:06 month:01 https://dx.doi.org/10.1186/2251-6581-13-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2014 1 06 01 |
| allfieldsGer |
10.1186/2251-6581-13-1 doi (DE-627)SPR033832560 (SPR)2251-6581-13-1-e DE-627 ger DE-627 rakwb eng Farahbakhsh-Farsi, Payam verfasserin aut Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 Djalali, Mahmoud aut Koohdani, Fariba aut Saboor-Yaraghi, Ali Akbar aut Eshraghian, Mohammad Reza aut Javanbakht, Mohammad Hassan aut Chamari, Maryam aut Djazayery, Abolghassem aut Enthalten in Journal of diabetes & metabolic disorders London : BioMed Centra, 2012 13(2014), 1 vom: 06. Jan. (DE-627)723900051 (DE-600)2680289-2 2251-6581 nnns volume:13 year:2014 number:1 day:06 month:01 https://dx.doi.org/10.1186/2251-6581-13-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2014 1 06 01 |
| allfieldsSound |
10.1186/2251-6581-13-1 doi (DE-627)SPR033832560 (SPR)2251-6581-13-1-e DE-627 ger DE-627 rakwb eng Farahbakhsh-Farsi, Payam verfasserin aut Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 Djalali, Mahmoud aut Koohdani, Fariba aut Saboor-Yaraghi, Ali Akbar aut Eshraghian, Mohammad Reza aut Javanbakht, Mohammad Hassan aut Chamari, Maryam aut Djazayery, Abolghassem aut Enthalten in Journal of diabetes & metabolic disorders London : BioMed Centra, 2012 13(2014), 1 vom: 06. Jan. (DE-627)723900051 (DE-600)2680289-2 2251-6581 nnns volume:13 year:2014 number:1 day:06 month:01 https://dx.doi.org/10.1186/2251-6581-13-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 13 2014 1 06 01 |
| language |
English |
| source |
Enthalten in Journal of diabetes & metabolic disorders 13(2014), 1 vom: 06. Jan. volume:13 year:2014 number:1 day:06 month:01 |
| sourceStr |
Enthalten in Journal of diabetes & metabolic disorders 13(2014), 1 vom: 06. Jan. volume:13 year:2014 number:1 day:06 month:01 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Omega-3 Acylation stimulating protein receptor (C5L2) Type 2 diabetes mellitus Gene expression |
| isfreeaccess_bool |
true |
| container_title |
Journal of diabetes & metabolic disorders |
| authorswithroles_txt_mv |
Farahbakhsh-Farsi, Payam @@aut@@ Djalali, Mahmoud @@aut@@ Koohdani, Fariba @@aut@@ Saboor-Yaraghi, Ali Akbar @@aut@@ Eshraghian, Mohammad Reza @@aut@@ Javanbakht, Mohammad Hassan @@aut@@ Chamari, Maryam @@aut@@ Djazayery, Abolghassem @@aut@@ |
| publishDateDaySort_date |
2014-01-06T00:00:00Z |
| hierarchy_top_id |
723900051 |
| id |
SPR033832560 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033832560</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519173122.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2251-6581-13-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033832560</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2251-6581-13-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Farahbakhsh-Farsi, Payam</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Omega-3</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acylation stimulating protein receptor (C5L2)</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type 2 diabetes mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene expression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djalali, Mahmoud</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koohdani, Fariba</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saboor-Yaraghi, Ali Akbar</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eshraghian, Mohammad Reza</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Javanbakht, Mohammad Hassan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chamari, Maryam</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djazayery, Abolghassem</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of diabetes & metabolic disorders</subfield><subfield code="d">London : BioMed Centra, 2012</subfield><subfield code="g">13(2014), 1 vom: 06. Jan.</subfield><subfield code="w">(DE-627)723900051</subfield><subfield code="w">(DE-600)2680289-2</subfield><subfield code="x">2251-6581</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:06</subfield><subfield code="g">month:01</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2251-6581-13-1</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">06</subfield><subfield code="c">01</subfield></datafield></record></collection>
|
| author |
Farahbakhsh-Farsi, Payam |
| spellingShingle |
Farahbakhsh-Farsi, Payam misc Omega-3 misc Acylation stimulating protein receptor (C5L2) misc Type 2 diabetes mellitus misc Gene expression Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| authorStr |
Farahbakhsh-Farsi, Payam |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)723900051 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2251-6581 |
| topic_title |
Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics Omega-3 (dpeaa)DE-He213 Acylation stimulating protein receptor (C5L2) (dpeaa)DE-He213 Type 2 diabetes mellitus (dpeaa)DE-He213 Gene expression (dpeaa)DE-He213 |
| topic |
misc Omega-3 misc Acylation stimulating protein receptor (C5L2) misc Type 2 diabetes mellitus misc Gene expression |
| topic_unstemmed |
misc Omega-3 misc Acylation stimulating protein receptor (C5L2) misc Type 2 diabetes mellitus misc Gene expression |
| topic_browse |
misc Omega-3 misc Acylation stimulating protein receptor (C5L2) misc Type 2 diabetes mellitus misc Gene expression |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Journal of diabetes & metabolic disorders |
| hierarchy_parent_id |
723900051 |
| hierarchy_top_title |
Journal of diabetes & metabolic disorders |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)723900051 (DE-600)2680289-2 |
| title |
Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| ctrlnum |
(DE-627)SPR033832560 (SPR)2251-6581-13-1-e |
| title_full |
Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| author_sort |
Farahbakhsh-Farsi, Payam |
| journal |
Journal of diabetes & metabolic disorders |
| journalStr |
Journal of diabetes & metabolic disorders |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
txt |
| author_browse |
Farahbakhsh-Farsi, Payam Djalali, Mahmoud Koohdani, Fariba Saboor-Yaraghi, Ali Akbar Eshraghian, Mohammad Reza Javanbakht, Mohammad Hassan Chamari, Maryam Djazayery, Abolghassem |
| container_volume |
13 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Farahbakhsh-Farsi, Payam |
| doi_str_mv |
10.1186/2251-6581-13-1 |
| title_sort |
effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| title_auth |
Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| abstract |
Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 |
| abstractGer |
Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 |
| abstract_unstemmed |
Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities. © Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
| container_issue |
1 |
| title_short |
Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics |
| url |
https://dx.doi.org/10.1186/2251-6581-13-1 |
| remote_bool |
true |
| author2 |
Djalali, Mahmoud Koohdani, Fariba Saboor-Yaraghi, Ali Akbar Eshraghian, Mohammad Reza Javanbakht, Mohammad Hassan Chamari, Maryam Djazayery, Abolghassem |
| author2Str |
Djalali, Mahmoud Koohdani, Fariba Saboor-Yaraghi, Ali Akbar Eshraghian, Mohammad Reza Javanbakht, Mohammad Hassan Chamari, Maryam Djazayery, Abolghassem |
| ppnlink |
723900051 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1186/2251-6581-13-1 |
| up_date |
2024-07-03T19:51:47.679Z |
| _version_ |
1803588791361863680 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033832560</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519173122.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2251-6581-13-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033832560</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2251-6581-13-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Farahbakhsh-Farsi, Payam</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of omega-3 supplementation versus placebo on acylation stimulating protein receptor gene expression in type 2 diabetics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Farahbakhsh-Farsi et al.; licensee BioMed Central Ltd. 2014</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background This randomized controlled trial investigated the role of omega-3 supplementation on C5L2 gene expression in type 2 diabetics. Methods Subjects in the omega-3 group received 4 g omega-3 per day and subjects in the placebo group took four capsules of placebo per day for 10 weeks. Gene expression was measured by RT- PCR at the beginning and end of the study. Results The results of this study show depletion in the omega-3 group, but the mean difference between two groups was not significant. Conclusions Understanding the effect of the omega-3 pathway could contribute to targeting treatment of diabetes and its comorbidities.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Omega-3</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acylation stimulating protein receptor (C5L2)</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Type 2 diabetes mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene expression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djalali, Mahmoud</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koohdani, Fariba</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saboor-Yaraghi, Ali Akbar</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eshraghian, Mohammad Reza</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Javanbakht, Mohammad Hassan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chamari, Maryam</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djazayery, Abolghassem</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of diabetes & metabolic disorders</subfield><subfield code="d">London : BioMed Centra, 2012</subfield><subfield code="g">13(2014), 1 vom: 06. Jan.</subfield><subfield code="w">(DE-627)723900051</subfield><subfield code="w">(DE-600)2680289-2</subfield><subfield code="x">2251-6581</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:06</subfield><subfield code="g">month:01</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2251-6581-13-1</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">06</subfield><subfield code="c">01</subfield></datafield></record></collection>
|
| score |
7.398514 |